Literature DB >> 29984411

Confidence intervals of the Mann-Whitney parameter that are compatible with the Wilcoxon-Mann-Whitney test.

Michael P Fay1, Yaakov Malinovsky2.   

Abstract

For the two-sample problem, the Wilcoxon-Mann-Whitney (WMW) test is used frequently: it is simple to explain (a permutation test on the difference in mean ranks), it handles continuous or ordinal responses, it can be implemented for large or small samples, it is robust to outliers, it requires few assumptions, and it is efficient in many cases. Unfortunately, the WMW test is rarely presented with an effect estimate and confidence interval. A natural effect parameter associated with this test is the Mann-Whitney parameter, φ = Pr[ X<Y ] + 0.5 Pr[X = Y ]. Ideally, we desire confidence intervals on φ that are compatible with the WMW test, meaning the test rejects at level α if and only if the 100(1 - α)% confidence interval on the Mann-Whitney parameter excludes 1/2. Existing confidence interval procedures on φ are not compatible with the usual asymptotic implementation of the WMW test that uses a continuity correction nor are they compatible with exact WMW tests. We develop compatible confidence interval procedures for the asymptotic WMW tests and confidence interval procedures for some exact WMW tests that appear to be compatible. We discuss assumptions and interpretation of the resulting tests and confidence intervals. We provide the wmwTest function of the asht R package to calculate all of the developed confidence intervals. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Mann-Whitney U test; Wilcoxon rank sum test; area under the curve; probabilistic index; receiver operating characteristic curve

Mesh:

Year:  2018        PMID: 29984411      PMCID: PMC6377068          DOI: 10.1002/sim.7890

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  13 in total

1.  The distribution of carriers of Streptococcus pyogenes among 2,413 healthy children.

Authors:  M C HOLMES; R E WILLIAMS
Journal:  J Hyg (Lond)       Date:  1954-06

2.  A comparison of confidence/credible interval methods for the area under the ROC curve for continuous diagnostic tests with small sample size.

Authors:  Dai Feng; Giuliana Cortese; Richard Baumgartner
Journal:  Stat Methods Med Res       Date:  2015-08-30       Impact factor: 3.021

3.  Ordinal probability effect measures for group comparisons in multinomial cumulative link models.

Authors:  Alan Agresti; Maria Kateri
Journal:  Biometrics       Date:  2016-07-20       Impact factor: 2.571

Review 4.  An analysis of the controversy over classical one-sided tests.

Authors:  Laurence S Freedman
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

5.  Confidence intervals that match Fisher's exact or Blaker's exact tests.

Authors:  Michael P Fay
Journal:  Biostatistics       Date:  2009-11-30       Impact factor: 5.899

Review 6.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

7.  Permutation-based inference for the AUC: A unified approach for continuous and discontinuous data.

Authors:  Markus Pauly; Thomas Asendorf; Frank Konietschke
Journal:  Biom J       Date:  2016-08-09       Impact factor: 2.207

8.  Exact significance testing to establish treatment equivalence with ordered categorical data.

Authors:  C R Mehta; N R Patel; A A Tsiatis
Journal:  Biometrics       Date:  1984-09       Impact factor: 2.571

9.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

10.  Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules.

Authors:  Michael P Fay; Michael A Proschan
Journal:  Stat Surv       Date:  2010
View more
  10 in total

1.  Simulation study comparing analytical methods for single-item longitudinal patient-reported outcomes data.

Authors:  Vinicius F Calsavara; Márcio A Diniz; Mourad Tighiouart; Patricia A Ganz; N Lynn Henry; Ron D Hays; Greg Yothers; André Rogatko
Journal:  Qual Life Res       Date:  2022-10-17       Impact factor: 3.440

Review 2.  Interpreting Results from Statistical Hypothesis Testing: Understanding the Appropriate P-value.

Authors:  Eiki Tsushima
Journal:  Phys Ther Res       Date:  2022-05-13

3.  Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2.

Authors:  Jonathan Fintzi; Tyler Bonnett; Pablo Tebas; Vincent C Marconi; Corri B Levine; Hana M El Sahly; Susan L F McLellan; Constance A Benson; Christina A Rostad; Anuradha Ganesan; Nikhil Huprikar; Maria G Frank; Richard A Mularski; Robert L Atmar; Pauline K Park; William R Short; John H Beigel; Aneesh K Mehta; Daniel A Sweeney
Journal:  Open Forum Infect Dis       Date:  2022-04-27       Impact factor: 4.423

4.  Causal estimands and confidence intervals associated with Wilcoxon-Mann-Whitney tests in randomized experiments.

Authors:  Michael P Fay; Erica H Brittain; Joanna H Shih; Dean A Follmann; Erin E Gabriel
Journal:  Stat Med       Date:  2018-05-17       Impact factor: 2.373

5.  The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study.

Authors:  Søren Vinther Larsen; Brice Ozenne; Kristin Köhler-Forsberg; Asbjørn Seenithamby Poulsen; Vibeke Høyrup Dam; Claus Svarer; Gitte Moos Knudsen; Martin Balslev Jørgensen; Vibe Gedso Frokjaer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-11       Impact factor: 5.555

6.  A Randomized Trial of Lipid Metabolism Modulation with Fenofibrate for Acute Coronavirus Disease 2019.

Authors:  Julio Chirinos; Patricio Lopez-Jaramillo; Evangelos Giamarellos-Bourboulis; Gonzalo Dávila-Del-Carpio; Abdul Bizri; Jaime Andrade-Villanueva; Oday Salman; Carlos Cure-Cure; Nelson Rosado-Santander; Mario Cornejo Giraldo; Luz González-Hernández; Rima Moghnieh; Rapti Angeliki; María Cruz Saldarriaga; Marcos Pariona; Carola Medina; Ioannis Dimitroulis; Charalambos Vlachopoulos; Corina Gutierrez; Juan Rodriguez-Mori; Edgar Gomez-Laiton; Rosa Pereyra; Jorge Ravelo Hernández; Hugo Arbañil; José Accini-Mendoza; Maritza Pérez-Mayorga; Haralampos Milionis; Garyfallia Poulakou; Gregorio Sánchez; Renzo Valdivia-Vega; Mirko Villavicencio-Carranza; Ricardo Ayala-Garcia; Carlos Castro-Callirgos; Rosa Alfaro Carrasco; Willy Lecca Danos; Tiffany Sharkoski; Katherine Greene; Bianca Pourmussa; Candy Greczylo; Jesse Chittams; Paraskevi Katsaounou; Zoi Alexiou; Styliani Sympardi; Nancy Sweitzer; Mary Putt; Jordana Cohen
Journal:  Res Sq       Date:  2022-08-10

7.  Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops.

Authors:  Madeleine T King; Margaret-Ann Tait; Rachel Campbell; Fabiola Müller; Claudia Rutherford; Corinna Beckmore; Sophie Chima; Danette Langbecker; Joanne Shaw; Rebecca Mercieca-Bebber
Journal:  Qual Life Res       Date:  2022-05-12       Impact factor: 3.440

8.  Baseline-adjusted proportional odds models for the quantification of treatment effects in trials with ordinal sum score outcomes.

Authors:  Muriel Buri; Armin Curt; John Steeves; Torsten Hothorn
Journal:  BMC Med Res Methodol       Date:  2020-05-06       Impact factor: 4.615

9.  Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index.

Authors:  Gillian Gresham; Márcio A Diniz; Zahra S Razaee; Michael Luu; Sungjin Kim; Ron D Hays; Steven Piantadosi; Mourad Tighiouart; Greg Yothers; Patricia A Ganz; André Rogatko
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

10.  Continuous monitoring in COVID-19 care: a retrospective study in time of crisis.

Authors:  Roy de Ree; Jorn Willemsen; Gilbert Te Grotenhuis; Rick de Ree; Joé Kolkert; Malou Peppelman
Journal:  JAMIA Open       Date:  2021-04-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.